Reblozyl 59572-0711-01

Generic: Luspatercept

Package NDC

59572-0711-01

Manufacturer: Celgene Corporation
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: November 8, 2019
Listing Expires: December 31, 2027
Application: BLA761136

Need to source Reblozyl? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Luspatercept	25 mg/1

Drug Class

Erythroid Maturation Agent [EPC]Erythroid Maturation Agent [EPC]Increased Erythroid Cell Production [PE]

Selected Package

59572-0711-01Selected

1 VIAL, GLASS in 1 CARTON (59572-711-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS